Impedimed Non Currrent Assets Other vs Intangible Assets Analysis

IPD Stock   0.04  0  2.50%   
Impedimed financial indicator trend analysis is infinitely more than just investigating Impedimed recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Impedimed is a good investment. Please check the relationship between Impedimed Non Currrent Assets Other and its Intangible Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Non Currrent Assets Other vs Intangible Assets

Non Currrent Assets Other vs Intangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Impedimed Non Currrent Assets Other account and Intangible Assets. At this time, the significance of the direction appears to have very week relationship.
The correlation between Impedimed's Non Currrent Assets Other and Intangible Assets is 0.26. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Impedimed, assuming nothing else is changed. The correlation between historical values of Impedimed's Non Currrent Assets Other and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Impedimed are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Non Currrent Assets Other i.e., Impedimed's Non Currrent Assets Other and Intangible Assets go up and down completely randomly.

Correlation Coefficient

0.26
Relationship DirectionPositive 
Relationship StrengthVery Weak

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.
Most indicators from Impedimed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Impedimed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
Tax Provision is likely to gain to about 40.3 K in 2025, whereas Selling General Administrative is likely to drop slightly above 13.6 M in 2025.
 2022 2023 2024 2025 (projected)
Cost Of Revenue25.0M1.3M1.5M1.4M
Total Revenue11.3M10.3M11.9M12.5M

Impedimed fundamental ratios Correlations

0.010.20.340.590.31-0.420.460.610.060.620.290.310.590.370.170.980.36-0.9-0.50.920.33-0.060.920.680.38
0.010.940.080.260.240.610.360.19-0.540.330.890.190.030.03-0.180.10.06-0.06-0.120.070.14-0.020.070.130.12
0.20.940.140.520.410.460.560.36-0.560.510.960.320.220.13-0.270.250.15-0.2-0.320.210.24-0.190.210.350.23
0.340.080.140.010.67-0.130.660.66-0.530.120.350.940.840.910.390.290.910.01-0.770.080.980.440.080.460.97
0.590.260.520.010.52-0.260.440.530.070.780.470.170.450.02-0.330.530.01-0.52-0.480.520.14-0.30.520.640.18
0.310.240.410.670.52-0.310.750.84-0.420.630.530.770.870.670.080.180.660.04-0.930.010.760.080.010.770.76
-0.420.610.46-0.13-0.26-0.31-0.24-0.39-0.31-0.340.37-0.06-0.44-0.17-0.13-0.23-0.140.180.45-0.18-0.10.14-0.18-0.6-0.17
0.460.360.560.660.440.75-0.240.74-0.660.490.710.80.760.670.00.370.67-0.13-0.860.170.72-0.130.170.790.77
0.610.190.360.660.530.84-0.390.74-0.360.630.520.720.870.660.30.520.65-0.27-0.870.330.740.150.330.890.73
0.06-0.54-0.56-0.530.07-0.42-0.31-0.66-0.36-0.09-0.66-0.66-0.37-0.530.020.05-0.55-0.240.470.2-0.58-0.090.2-0.27-0.57
0.620.330.510.120.780.63-0.340.490.63-0.090.520.210.540.260.030.530.25-0.49-0.590.490.21-0.240.490.80.21
0.290.890.960.350.470.530.370.710.52-0.660.520.510.380.35-0.080.320.36-0.19-0.480.210.43-0.130.210.480.42
0.310.190.320.940.170.77-0.060.80.72-0.660.210.510.850.890.230.250.890.05-0.840.040.980.260.040.540.97
0.590.030.220.840.450.87-0.440.760.87-0.370.540.380.850.820.20.480.81-0.23-0.940.30.880.240.30.790.9
0.370.030.130.910.020.67-0.170.670.66-0.530.260.350.890.820.510.311.0-0.03-0.770.110.90.280.110.520.87
0.17-0.18-0.270.39-0.330.08-0.130.00.30.020.03-0.080.230.20.510.180.52-0.02-0.150.060.310.280.060.150.2
0.980.10.250.290.530.18-0.230.370.520.050.530.320.250.480.310.180.31-0.94-0.360.970.27-0.030.970.550.31
0.360.060.150.910.010.66-0.140.670.65-0.550.250.360.890.811.00.520.31-0.03-0.760.110.910.280.110.510.87
-0.9-0.06-0.20.01-0.520.040.18-0.13-0.27-0.24-0.49-0.190.05-0.23-0.03-0.02-0.94-0.030.11-0.990.030.16-0.99-0.37-0.02
-0.5-0.12-0.32-0.77-0.48-0.930.45-0.86-0.870.47-0.59-0.48-0.84-0.94-0.77-0.15-0.36-0.760.11-0.17-0.83-0.08-0.17-0.86-0.85
0.920.070.210.080.520.01-0.180.170.330.20.490.210.040.30.110.060.970.11-0.99-0.170.06-0.091.00.40.11
0.330.140.240.980.140.76-0.10.720.74-0.580.210.430.980.880.90.310.270.910.03-0.830.060.390.060.530.98
-0.06-0.02-0.190.44-0.30.080.14-0.130.15-0.09-0.24-0.130.260.240.280.28-0.030.280.16-0.08-0.090.39-0.09-0.090.37
0.920.070.210.080.520.01-0.180.170.330.20.490.210.040.30.110.060.970.11-0.99-0.171.00.06-0.090.40.11
0.680.130.350.460.640.77-0.60.790.89-0.270.80.480.540.790.520.150.550.51-0.37-0.860.40.53-0.090.40.56
0.380.120.230.970.180.76-0.170.770.73-0.570.210.420.970.90.870.20.310.87-0.02-0.850.110.980.370.110.56
Click cells to compare fundamentals

Impedimed Account Relationship Matchups

Impedimed fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets34.2M58.7M68.7M47.0M54.0M37.4M
Other Current Liab5.6M3.5M3.2M3.2M3.7M3.0M
Total Current Liabilities8.1M7.2M5.8M4.7M5.4M4.8M
Other Liab87K398K413K864K993.6K1.0M
Accounts Payable1.3M2.6M1.4M1.1M1.3M1.4M
Net Receivables2.8M2.7M2.6M2.2M2.5M1.4M
Good Will2.4M2.6M2.7M2.7M3.1M2.5M
Inventory372K926K810K759K683.1K912.9K
Other Current Assets2.8M2.3M2.8M1.9M2.2M1.7M
Total Liab8.7M7.7M7.9M6.2M7.2M5.2M
Intangible Assets7.5M11.4M14.8M13.3M15.3M16.1M
Common Stock267.3M307.6M336.1M336.1M386.6M405.9M
Property Plant Equipment1.0M418K2.0M1.4M1.7M1.7M
Short Long Term Debt Total474K170K1.4M1.1M1.3M799.6K
Total Stockholder Equity25.5M51.0M60.9M40.7M46.9M34.4M
Property Plant And Equipment Net1.0M418K2.0M1.4M1.7M1.7M
Net Debt(19.2M)(40.6M)(44.3M)(23.5M)(21.1M)(22.2M)
Retained Earnings(270.8M)(290.6M)(311.2M)(331.0M)(297.9M)(283.0M)
Cash19.7M40.7M45.7M24.6M28.3M28.3M
Non Current Assets Total8.6M12.0M16.8M17.5M20.2M21.2M
Non Currrent Assets Other(8.6M)(11.9M)(16.8M)13.3M12.0M12.6M
Cash And Short Term Investments19.7M40.7M45.7M24.6M28.3M28.3M
Common Stock Shares Outstanding1.2B1.7B1.8B2.0B2.3B2.4B
Liabilities And Stockholders Equity34.2M58.7M68.7M47.0M54.0M39.2M
Non Current Liabilities Total557K413K2.0M1.6M1.8M1.9M
Property Plant And Equipment Gross3.4M3.8M5.6M5.7M6.5M6.8M
Total Current Assets25.7M46.7M51.9M29.5M33.9M32.8M
Accumulated Other Comprehensive Income29.0M34.1M36.0M35.5M40.9M42.9M
Short Term Debt(562K)(758K)141K333K299.7K314.7K
Net Tangible Assets20.8M18.1M39.7M46.1M41.5M28.0M
Current Deferred Revenue877K928K1.0M1.5M1.7M1.8M
Long Term Investments73K75K78K54K48.6K62.5K
Net Invested Capital25.5M51.0M60.9M40.7M46.9M43.5M
Cash And Equivalents11.5M31.3M13.5M18.4M16.5M16.7M
Net Working Capital17.5M39.4M46.1M24.8M22.3M24.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Impedimed Stock Analysis

When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.